Literature DB >> 20140115

Prescribing trends with levalbuterol (xopenex) at a community hospital.

Nicole D Verkleeren, Krista M Lipchick.   

Abstract

Entities:  

Year:  2009        PMID： 20140115      PMCID： PMC2799148     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  15 in total

1.  A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.

Authors:  Richard Nowak; Charles Emerman; John P Hanrahan; Merdad V Parsey; Nicola A Hanania; Raymond Claus; Kendyl Schaefer; Rudolf A Baumgartner
Journal:  Am J Emerg Med       Date:  2006-05       Impact factor: 2.469

Review 2.  Clinical experience with levalbuterol.

Authors:  H S Nelson
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

3.  Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma.

Authors:  M Perrin-Fayolle; P S Blum; J Morley; M Grosclaude; M T Chambe
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

4.  Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.

Authors:  James F Donohue; Merdad V Parsey; Charles Andrews; Tony D'Urzo; Satyendra Sharma; Kendyl Schaefer; Raymond Claus; Rudolf A Baumgartner
Journal:  COPD       Date:  2006-08       Impact factor: 2.409

Review 5.  Beta-adrenergic bronchodilators.

Authors:  H S Nelson
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

6.  Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.

Authors:  D A Handley; D Tinkelman; M Noonan; T E Rollins; M E Snider; J Caron
Journal:  J Asthma       Date:  2000-06       Impact factor: 2.515

7.  An evaluation of nebulized levalbuterol in stable COPD.

Authors:  Debapriya Datta; Anthony Vitale; Bimalin Lahiri; Richard ZuWallack
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

8.  A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.

Authors:  Kenneth Tripp; William K McVicar; Parameswaran Nair; Jonathan Corren; Warren W Pleskow; Elizabeth Goodwin; Rudolf A Baumgartner; John P Hanrahan
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

9.  Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.

Authors:  Sum Lam; Julie Chen
Journal:  Am J Health Syst Pharm       Date:  2003-10-01       Impact factor: 2.637

10.  Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

Authors:  James F Donohue; Nicola A Hanania; Ronald L Ciubotaru; Les Noe; David J Pasta; Kendyl Schaefer; Raymond Claus; William T Andrews; James Roach
Journal:  Clin Ther       Date:  2008       Impact factor: 3.393
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.